✦ LIBER ✦

Phase II study of sequential dose-dense paclitaxel followed by topotecan in extensive small-cell lung cancer (SCLC)

✍ Scribed by L. Santome; E. Felip; R. Rosell; M. Domine; A. Font; P. Garrido; A. Carrato; J. Terrasa; J. Mañe; J. Baselga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary results of sequential dose-d

✍ Felip, E; Font, A; Rosell, R; Garrido, P; Carrato, A; Terrasa, S; Mane, J; Santo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 246 KB

The sequential administration of cisplat

✍ D. Mavroudis; S. Agelaki; Ph. Palamidas; Ch. Kouroussis; A. Harpidou; M. Toubis; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase II study of topotecan (TOP) for re

✍ Ogawara, M; Negoro, S; Nishiwaki, Y; Fukuoka, M; Watanabe, K; Niitani, H 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Sequential administration of cisplatin–e

✍ Mavroudis, D; Pavlakou, G; Blazoyiannakis, G; Veslemes, M; Apostolopoulou, F; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB